abstract |
VASOPRESSIN-2 RECEPTOR AGONISTS. The present invention relates to vasopressin-2 receptor agonists, pharmaceutical compositions thereof, and methods of using the foregoing for the treatment of diabetes insipidus, primary nocturnal enuresis, and nocturia. |